Description
Deboc-cabazitaxel or De-boc-cabazitaxel is an impurity in the synthesis of cabazitaxel. The latter is an anti-cancer agent derived from taxol. Cabazitaxel is used in the treatment of castration-resistant prostate cancer.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Deboc-cabazitaxel or De-boc-cabazitaxel is an impurity in the synthesis of cabazitaxel. The latter is an anti-cancer agent derived from taxol. Cabazitaxel is used in the treatment of castration-resistant prostate cancer.
| Cas No. | 1638286-64-2 |
|---|---|
| Purity | ≥95% |
| Formula | C40H49NO12 |
| Formula Wt. | 735.83 |
| Synonym | De-boc-Cabazitaxel |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
5-Lipoxygenase inhibitor.
Bisaniline pyrimidine; pan-kinase inhibitor.
Acyl transfer catalyst, involved in peptide syn...
Aminothiol, CoA component; ulcer inducer.
FLT3, PDGFR, c-Kit inhibitor.
AMPK activator.
Wortmannin analog; PI3K inhibitor.
Peptide, involved in neutrophil activation; FPR...
GABA-A agonist.
EGFR inhibitor.
Endogenous opioid peptide; μOR agonist.
Diketopiperazine produced by Aspergillus; micro...
Steroidal jerveratrum alkaloid found in Veratru...
Mycotoxin produced by Aspergillus and Penicillu...
NSAID; COX-1/2 inhibitor.
p110α PI3K and mTOR inhibitor.
5-HT2 antagonist, SERT and NET inhibitor, hERG ...
Xanthone found in Garcinia hanburyi.
Benzopyrone found in various plants, precursor ...
ATP competitive CDK inhibitor.